CLL

Showing 26 - 43 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The Capability of Haemato-oncology Patients to Generate

Active, not recruiting
  • CLL
  • +2 more
    • Tel Aviv, Israel
      Tel-Aviv Sourasky Medical Center
    Aug 8, 2021

    Leukemia, CLL Trial in Houston (Lenalidomide)

    Completed
    • Leukemia
    • CLL
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jun 30, 2021

    Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, AML, Adult Trial in Orange (Pitavastatin, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Mar 25, 2021

    Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

    Completed
    • Blood Cancer
    • +7 more
    • non-myeloablative hematopoietic cell transplantation
    • +8 more
    • Stanford, California
      Stanford University School of Medicine
    Nov 17, 2019

    Chronic Lymphocytic Leukemia Electronic Patient Reported

    Completed
    • CLL
    • Carevive CPS
    • Tampa, Florida
      Moffitt Cancer Institute
    Aug 23, 2019

    Allogeneic Hematopoietic Stem Cell Transplantation in 17p-

    Completed
    • CLL
      • Copenhagen, Denmark
      • +9 more
      Aug 14, 2019

      Leukemia, CLL, Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide)

      Completed
      • Leukemia
      • +3 more
      • Houston, Texas
        UT MD Anderson Cancer Center
      Jul 23, 2018

      CLL Trial in La Jolla (Ofatumumab/HDMP)

      Completed
      • CLL
      • La Jolla, California
      • +1 more
      Apr 9, 2018

      Safety of Chlorambucil + Rituximab in CLL Patients

      Unknown status
      • CLL
      • +4 more
        • Ascoli Piceno, Italy
        • +19 more
        Mar 21, 2018

        Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)

        Terminated
        • Hematologic Malignancy
        • +11 more
        • Total Body Irradiation (TBI)
        • +5 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Oct 19, 2016

        AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

        Completed
        • AML
        • +8 more
        • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        Jul 14, 2016

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL Trial in La Jolla (A6)

        Terminated
        • Chronic Lymphocytic Leukemia
        • +3 more
        • La Jolla, California
          Moores Cancer Center, UCSD
        Jul 11, 2016

        Peptide-drug-conjugates for Personalized, Targeted Therapy of

        Unknown status
        • CLL
        • there will be no intervention.
        • (no location specified)
        Jul 7, 2016

        CLL, Chronic Lymphocytic Leukemia Trial in Innsbruck, Salzburg (Lenalidomide)

        Completed
        • CLL
        • Chronic Lymphocytic Leukemia
        • Innsbruck, Tirol, Austria
        • +1 more
        May 25, 2016

        Heavy Light Chain in Chronic Lymphocytic Leukemia

        Unknown status
        • CLL
        • No intervantion
        • Haifa, Israel
          Bnai Zion Medical Center
        Feb 25, 2015

        Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)

        Unknown status
        • Chronic Lymphocytic Leukemia
        • +5 more
        • Lenalidomide and Rituximab
        • La Jolla, California
        • +4 more
        Sep 8, 2010

        Chronic Lymphocytic Leukemia, CLL Trial in New Hyde Park, Houston, San Antonio (Oblimerson sodium, G3139)

        Completed
        • Chronic Lymphocytic Leukemia
        • CLL
        • Oblimerson sodium, G3139
        • New Hyde Park, New York
        • +2 more
        Nov 10, 2009